Decreased growth in ART exposed uninfected infants in Botswana
25 July 2013. Related: Conference reports, Antiretrovirals, Pregnancy, Paediatric care.
Conference reports
Antiretrovirals, doses and formulations for children
25 July 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, 4-8 June 2013, Toronto
25 July 2013. Related: Conference reports.
Higher intracellular concentrations with tenofovir alafenamide (TAF) overcomes K65R and other key NRTI resistance in vitro
25 July 2013. Related: Conference reports, Antiretrovirals, Drug resistance.
Tentative phenotypic cut offs for dolutegravir: guidance for use with integrase resistance
25 July 2013. Related: Conference reports, Antiretrovirals, Drug resistance.
S/GSK744 and long-acting formulation indicate broadly similar resistance profile to dolutegravir
25 July 2013. Related: Conference reports, Antiretrovirals, Drug resistance.
One in five people with recent HIV infection in Spain have X4/R5 mixed tropic virus
25 July 2013. Related: Conference reports, Virology.
14th International Workshop on Clinical Pharmacology, 22-24 April 2013, Amsterdam
29 May 2013. Related: Conference reports.
Population pharmacokinetics of efavirenz to inform dosing in children three months of age and above
29 May 2013. Related: Conference reports, Paediatric care, PK and drug interactions.
Bilirubin as a surrogate marker for atazanavir in children
29 May 2013. Related: Conference reports, Paediatric care, PK and drug interactions.
Transplacental transfer of atazanavir and neonatal hyperbilirubinaemia
29 May 2013. Related: Conference reports, Pregnancy, PK and drug interactions.
Tenofovir population pharmacokinetics in pregnancy
29 May 2013. Related: Conference reports, Pregnancy, PK and drug interactions.
Effect of rifampicin on BMS-663068 in HIV negative volunteers
29 May 2013. Related: Conference reports, PK and drug interactions.
Coformulated darunavir/cobicistat: an alternative to separate ritonavir boosting
29 May 2013. Related: Conference reports, PK and drug interactions.
Continuous infusion of T-20 in multidrug resistant patient with intolerance of s.c. injections
29 May 2013. Related: Conference reports, PK and drug interactions.
20th Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2013, Atlanta
29 May 2013. Related: Conference reports.
Small increase in birth defects in the French Perinatal Cohort
29 May 2013. Related: Conference reports, Antiretrovirals, Pregnancy.
Uptake and retention in Malawi’s Option B+ programme
29 May 2013. Related: Conference reports, Antiretrovirals, Pregnancy.
Optimising ART initiation in pregnancy through linkage of services vs integration of ART into antenatal care
29 May 2013. Related: Conference reports, Antiretrovirals, Pregnancy.
Cardiovascular disease and other non-AIDS defining events
29 May 2013. Related: Conference reports, Coinfections and complications.
Dramatic advances at CROI for HCV treatment: telaprevir, boceprevir, faldaprevir, sofosbuvir, ABT-450, ABT-267, ABT-333 and ledipasvir
29 May 2013. Related: Conference reports, Hepatitis coinfection.
Basic research highlights from CROI 2013
29 May 2013. Related: Conference reports, Basic science and immunology.
Probiotic/prebiotic supplement combination shows benefits in SIV-infected pigtailed macaques
29 May 2013. Related: Conference reports, Basic science and immunology.
20th Conference on Retroviruses and Opportunistic Infections (CROI) 3-6 March 2013, Atlanta
1 April 2013. Related: Conference reports.
ARV pipeline: dolutegravir, TAF (GS-7340), MK-1439 and cenicriviroc
1 April 2013. Related: Conference reports, Antiretrovirals.
ARV pipeline: long-acting formulations of rilpivirine, GSK-744 and nanoformulations
1 April 2013. Related: Conference reports, Antiretrovirals.
Five-year results from the AntiRetroviral Research for Watoto (ARROW) Trial
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
Comparison of ritonavir-boosted lopinavir or NNRTI ART and PK with antimalarials in Ugandan children
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
Pharmacokinetics and acceptability of lopinavir/ritonavir sprinkles in children aged 1 to 4 years
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
Pharmacokinetics of currently available antiretroviral options for young children
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
Safety of transplacental raltegravir in neonates and washout pharmacokinetics
1 April 2013. Related: Conference reports, Antiretrovirals, Pregnancy, PK and drug interactions.
Tenofovir use in children
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
ddI resistance in South African children failing an abacavir or d4T based first-line regimen
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care, Drug resistance.
Statin use in HIV positive people
1 April 2013. Related: Conference reports, Side effects.
RIFAQUIN study demonstrates once-weekly dosing during follow-up phase of TB treatment
1 April 2013. Related: Conference reports, Coinfections and complications, TB coinfection.
Combining Xpert and LAM urine testing improves TB diagnostic sensitivity
1 April 2013. Related: Conference reports, Diagnostics, Coinfections and complications, TB coinfection.
Deferring ART by four weeks reduces mortality in patients diagnosed with cryptococcal meningitis
1 April 2013. Related: Conference reports, Coinfections and complications.
Monthly injection protects macaques from rectal exposure: results should fast-track human studies for advanced PrEP options
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Tenofovir DF ring protects macaques from vaginal exposure
1 April 2013. Related: Conference reports, HIV prevention and transmission.
VOICE study reports low adherence as reason for lack of efficacy for PrEP: anal sex common in African heterosexuals
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Further studies on how male circumcision may reduce HIV transmission
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Report of a functional cure in an HIV infected infant
1 April 2013. Related: Conference reports, Paediatric care, Cure-related research.
3rd International Workshop on HIV and Women, 14-15 January 2013, Toronto
1 February 2013. Related: Conference reports.
Nevirapine-containing ART does not reduce combined oral contraceptive effectiveness
1 February 2013. Related: Conference reports, Antiretrovirals, Women's health.
Minimal risk of sexual HIV transmission for heterosexual couples when the HIV positive partner has an undetectable viral load
1 February 2013. Related: Conference reports, Women's health, HIV prevention and transmission.
Differences by age for women in response to initial ART: meta-analysis from clinical studies submitted to the FDA
1 February 2013. Related: Conference reports, Antiretrovirals, Women's health.
Lopinavir/ritonavir in pregnancy: results from a systematic review
1 February 2013. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Possible mechanisms for adverse pregnancy outcomes in HIV positive women
1 February 2013. Related: Conference reports, Women's health, Pregnancy.
43rd Union World Conference on Lung Health, 13-17 November 2012, Kuala Lumpur, Malaysia.
1 February 2013. Related: Conference reports.
Paediatric TB: glimpses of PK data and a potential new approach to drug development
1 February 2013. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
11th International Congress on Drug Therapy in HIV, 11-15 November 2012, Glasgow
1 December 2012. Related: Conference reports.
Issues that divide expert opinion: when to start, HIV and ageing and the impact of HIV on life expectancy
1 December 2012. Related: Conference reports, Ageing and life expectancy.
Dolutegravir: integrase resistance and the impact of the background regimen
1 December 2012. Related: Conference reports, Antiretrovirals.
Updated results on Quad: 96 week data from phase 3 studies
1 December 2012. Related: Conference reports, Antiretrovirals.
HIV/HCV coinfection: early glimpses of an interferon-free future and EuroSIDA incidence data
1 December 2012. Related: Conference reports, Hepatitis coinfection.
Resistance in infants and children receiving ART in South Africa
1 December 2012. Related: Conference reports, Paediatric care.
63rd Annual Meeting of the American Association for the Study of Liver Disease (AASLD), 9-13 November 2012, Boston
1 December 2012. Related: Conference reports.
Cure rates with pipeline HCV drugs: reports from AASLD
1 December 2012. Related: Conference reports, Hepatitis coinfection.
3rd International Workshop on HIV and ageing, 5-6 November 2012, Baltimore
1 December 2012. Related: Conference reports.
BHIVA Autumn Conference, 6-7 October 2012, London
1 December 2012. Related: Conference reports.
52nd International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 9-12 September 2012, San Francisco
1 October 2012. Related: Conference reports.
Study summaries from ICAAC 2012
1 October 2012. Related: Conference reports, Antiretrovirals, Basic science and immunology.
Antiviral activity in vitro with S/GSK1265744
1 October 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Efavirenz interaction studies with TB compounds bedaquiline and delamanid
1 October 2012. Related: Conference reports, Antiretrovirals, PK and drug interactions.
19th IAS World AIDS Conference, 22–25 July 2012, Washington
1 October 2012. Related: Conference reports.